Target Name: MIR6845
NCBI ID: G102466748
Review Report on MIR6845 Target / Biomarker Content of Review Report on MIR6845 Target / Biomarker
MIR6845
Other Name(s): hsa-miR-6845-3p | hsa-miR-6845-5p | MicroRNA 6845 | hsa-mir-6845 | microRNA 6845

MIR6845: A Potential Drug Target and Biomarker

MIR6845 (hsa-miR-6845-3p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression patterns have made it an attractive target for researchers to study, and its potential as a drug have piqued the interest of pharmaceutical companies.

MIR6845 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in regulating gene expression. It is expressed in a variety of tissues and cells and is involved in the regulation of various biological processes, including cell growth, apoptosis, and inflammation.

One of the key features of MIR6845 is its unique structure. It is a single-stranded RNA molecule that has a length of approximately 200 nucleotides. It has a characteristic stem-loop structure, which is a type of loop that is commonly found in miRNAs. The stem-loop region of MIR6845 is responsible for its unique expression patterns and is involved in its ability to interact with other molecules.

Another important feature of MIR6845 is its expression patterns. It is expressed in a variety of tissues and cells, including human pluripotent stem cells, cancer cells, and tissues from various organisms. Its expression patterns are regulated by various factors, including the cell cycle, apoptosis, and inflammation. This makes it an attractive target for researchers to study and potentially identify potential drug targets.

MIR6845 has also been shown to play a role in the regulation of cell apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells. MIR6845 has been shown to be involved in the regulation of cell apoptosis by activating the Bcl-2 protein. Bcl-2 is a protein that has been shown to promote cell survival and prevent apoptosis. By activating Bcl-2, MIR6845 has been shown to promote the survival of cancer cells, which could make it an attractive target for cancer treatments.

MIR6845 has also been shown to be involved in the regulation of inflammation. It has been shown to be regulated by various factors, including inflammation and pain. This makes it an attractive target for drugs that are designed to treat inflammatory diseases.

In addition to its potential as a drug target, MIR6845 has also been shown to have potential as a biomarker. Its expression patterns have been shown to be regulated by various factors, including the cell cycle, apoptosis, and inflammation. This makes it an attractive target for biomarkers that can be used to diagnose and monitor various diseases.

In conclusion, MIR6845 is a unique and attractive target for drug research due to its unique structure and expression patterns. Its potential as a drug target and biomarker make it an attractive target for pharmaceutical companies to explore. Further research is needed to fully understand its potential as a drug and to identify its potential as a biomarker.

Protein Name: MicroRNA 6845

The "MIR6845 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6845 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2 | MIR6859-3 | MIR6859-4 | MIR6860 | MIR6861 | MIR6862-1 | MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704